Plasma Protein Therapeutics Market by Product and Application- Global Industry Analysis and Forecast to 2023
Published On : January 2018 Pages : 80 Category: Pharmaceuticals Report Code : HC01554
Industry Outlook and Trend Analysis
The global Plasma Protein Therapeutics Market was worth USD 17.35 billion in 2017 and is expected to reach approximately USD 32.51 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 7.23% during the forecast period. Plasma is a protein rich liquid and plays a vital part in coagulating and giving immunity to maladies. By confining the proteins from plasma, they can be used for medical treatments including immune deficiencies, autoimmune, bleeding and neurological disorders. Plasma protein treatments are used to treat all around characterized therapeutic condition by supplanting the insufficient or missing proteins in plasma. Plasma protein therapeutics includes organic prescriptions either mixed or infused to treat hazardous, incessant and genetic diseases.
Drivers and Restraints
Expanding advent of new plasma-derived treatments is the essential driving variable for the market. The market is additionally determined by a large group of different variables, including rising predominance of dangerous sicknesses including safe or neurological systems and different irresistible illnesses like Tetanus, Hepatitis A&B, Rabies and varicella. Despite what might be expected there are a couple of limitations for market which incorporates stringent government regulations, complications in manufacturing and issues related to reimbursement
Market Segmentation
The Plasma Protein Therapeutics Market is segmented on the basis of product and Application. Based on product the market is segmented into Albumin, Immunoglobulins, alpha-1 proteinase inhibitor, Coagulation Factors and others. On the basis of applications the market is segmented into Primary Immunodeficiency Disorder, Hemophilia, Secondary Immunodeficiency Idiopathic Thrombocytopenic Purpura and others.
Regional Outlook and Trend Analysis
In 2017 North America ruled the plasma protein therapeutic market with most elevated volume of blood gathering and developing interest for the plasma proteins. As per the information published by the Plasma Protein Therapy Association (PPTA), it is evaluated that in 2017, North America procured over 40% of the plasma protein therapeutic market. Consciousness of individuals for normal blood donations, existence of business associations with modern advancements for fractionating techniques and high discretionary income of the general population are the main thrusts of the market.
Competitive Insights
The leading players in the market are Grifols, Chengdu Institute of Biological Products, Baxter International, Octapharma, China Biologic Products, Shire, Biotest and CSL Behring. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Plasma Protein Therapeutics Market is segmented as follows-
By Product:
- Immunoglobulins
- Albumin
- Coagulation Factors
- Alpha-1 Proteinase Inhibitor
- Others
By Application:
- Hemophilia
- Primary Immunodeficiency Disorder
- Idiopathic Thrombocytopenic Purpura
- Secondary Immunodeficiency
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Plasma Protein Therapeutics Market , By Product, Estimates and Forecast, 2014-2023 ($Million)
- Immunoglobulins
- Albumin
- Coagulation Factors
- Alpha-1 Proteinase Inhibitor
- Others
- Plasma Protein Therapeutics Market , By Application, Estimates and Forecast, 2014-2023 ($Million)
- Hemophilia
- Primary Immunodeficiency Disorder
- Idiopathic Thrombocytopenic Purpura
- Secondary Immunodeficiency
- Others Plasma Protein Therapeutics Market , By Region, Estimates and Forecast, 2014-2023 ($Million)
- North America
- North America Plasma Protein Therapeutics Market , By Country
- North America Plasma Protein Therapeutics Market , By Product
- North America Plasma Protein Therapeutics Market , By Application
- U.S. Plasma Protein Therapeutics Market , By Product
- U.S. Plasma Protein Therapeutics Market , By Application
- Canada Plasma Protein Therapeutics Market , By Product
- Canada Plasma Protein Therapeutics Market , By Application
- Mexico Plasma Protein Therapeutics Market , By Product
- Mexico Plasma Protein Therapeutics Market , By Application
-
- Europe
- Europe Plasma Protein Therapeutics Market , By Country
- Europe Plasma Protein Therapeutics Market , By Product
- Europe Plasma Protein Therapeutics Market , By Application
- Germany Plasma Protein Therapeutics Market , By Product
- Germany Plasma Protein Therapeutics Market , By Application
- France Plasma Protein Therapeutics Market , By Product
- France Plasma Protein Therapeutics Market , By Application
- UK Plasma Protein Therapeutics Market , By Product
- UK Plasma Protein Therapeutics Market , By Application
- Italy Plasma Protein Therapeutics Market , By Product
- Italy Plasma Protein Therapeutics Market , By Application
- Spain Plasma Protein Therapeutics Market , By Product
- Spain Plasma Protein Therapeutics Market , By Application
- Rest of Europe Plasma Protein Therapeutics Market , By Product
- Rest of Europe Plasma Protein Therapeutics Market , By Application
-
- Asia-Pacific
- Asia-Pacific Plasma Protein Therapeutics Market , By Country
- Asia-Pacific Plasma Protein Therapeutics Market , By Product
- Asia-Pacific Plasma Protein Therapeutics Market , By Application
- Japan Plasma Protein Therapeutics Market , By Product
- Japan Plasma Protein Therapeutics Market , By Application
- Australia Plasma Protein Therapeutics Market , By Product
- Australia Plasma Protein Therapeutics Market , By Application
- India Plasma Protein Therapeutics Market , By Product
- India Plasma Protein Therapeutics Market , By Application
- South Korea Plasma Protein Therapeutics Market , By Product
- South Korea Plasma Protein Therapeutics Market , By Application
- Rest of Asia-Pacific Plasma Protein Therapeutics Market , By Product
- Rest of Asia-Pacific Plasma Protein Therapeutics Market , By Application
- Asia-Pacific
-
- Rest of the World
- Rest of the World Plasma Protein Therapeutics Market , By Country
- Rest of the World Plasma Protein Therapeutics Market , By Product
- Rest of the World Plasma Protein Therapeutics Market , By Application
- Brazil Plasma Protein Therapeutics Market , By Product
- Brazil Plasma Protein Therapeutics Market , By Application
- South Africa Plasma Protein Therapeutics Market , By Product
- South Africa Plasma Protein Therapeutics Market , By Application
- Saudi Arabia Plasma Protein Therapeutics Market , By Product
- Saudi Arabia Plasma Protein Therapeutics Market , By Application
- Turkey Plasma Protein Therapeutics Market , By Product
- Turkey Plasma Protein Therapeutics Market , By Application
- United Arab Emirates Plasma Protein Therapeutics Market , By Product
- United Arab Emirates Plasma Protein Therapeutics Market , By Application
- Others Plasma Protein Therapeutics Market , By Product
- Others Plasma Protein Therapeutics Market , By Application
- Rest of the World
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Expanding advent of new plasma-derived treatments
3.2.2. Restraints
3.2.3. Opportunities
4. Plasma Protein Therapeutics Market , By Product
4.1. Introduction
4.2. Global Plasma Protein Therapeutics Sales, Revenue and Market Share By Product (2017-2017)
4.2.1. Global Plasma Protein Therapeutics Sales and Sales Share By Product (2017-2017)
4.2.2. Global Plasma Protein Therapeutics Revenue and Revenue Share By Product (2017-2017)
4.3. Plasma Protein Therapeutics Market Assessment and Forecast, By Product, 2017-2023
4.4. Immunoglobulins
4.4.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
4.5. Albumin
4.5.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
4.6. Coagulation Factors
4.6.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
4.7. Alpha-1 Proteinase Inhibitor
4.7.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
4.8. Others
4.8.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5. Plasma Protein Therapeutics Market , By Application
5.1. Introduction
5.2. Global Plasma Protein Therapeutics Sales, Revenue and Market Share by Application (2017-2017)
5.2.1. Global Plasma Protein Therapeutics Sales and Sales Share by Application (2017-2017)
5.2.2. Global Plasma Protein Therapeutics Revenue and Revenue Share by Application (2017-2017)
5.3. The Plasma Protein Therapeutics Market Assessment and Forecast, By Application, 2017-2023
5.4. Hemophilia
5.4.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.5. Primary Immunodeficiency Disorder
5.5.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.6. Idiopathic Thrombocytopenic Purpura
5.6.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.7. Secondary Immunodeficiency
5.7.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.8. Others
5.8.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
6. Plasma Protein Therapeutics Market , By Region
6.1. Introduction
6.2. Plasma Protein Therapeutics Market Assessment and Forecast, By Region, 2017-2023 ($Million)
6.3. Global Plasma Protein Therapeutics Sales, Revenue and Market Share by Regions
6.3.1. Global Plasma Protein Therapeutics Sales by Regions (2017-2017)
6.3.2. Global Plasma Protein Therapeutics Revenue by Regions (2017-2017)
6.4. North America
6.4.1. North America Plasma Protein Therapeutics Sales and Growth Rate (2017-2017)
6.4.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.4.3. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.4.4. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.4.5. U.S.
6.4.5.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.4.5.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.4.6. Canada
6.4.6.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.4.6.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.4.7. Mexico
6.4.7.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.4.7.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5. Europe
6.5.1. Europe Plasma Protein Therapeutics Sales and Growth Rate (2017-2017)
6.5.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.5.3. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.5.4. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.5. Germany
6.5.5.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.5.5.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.6. France
6.5.6.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.5.6.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.7. UK
6.5.7.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.5.7.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.8. Italy
6.5.8.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.5.8.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.9. Spain
6.5.9.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.5.9.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.10. Rest of Europe
6.5.10.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.5.10.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6. Asia-Pacific
6.6.1. Asia-Pacific Plasma Protein Therapeutics Sales and Growth Rate (2017-2017)
6.6.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.6.3. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.6.4. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.5. Japan
6.6.5.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.6.5.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.6. China
6.6.6.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.6.6.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.7. Australia
6.6.7.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.6.7.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.8. India
6.6.8.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.6.8.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.9. South Korea
6.6.9.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.6.9.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.10. Rest of Asia-Pacific
6.6.10.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.6.10.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7. Rest of the World
6.7.1. Rest of the World Plasma Protein Therapeutics Sales and Growth Rate (2017-2017)
6.7.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.7.3. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.7.4. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.5. Brazil
6.7.5.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.7.5.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.6. Turkey
6.7.6.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.7.6.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.7. Saudi Arabia
6.7.7.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.7.7.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.8. South Africa
6.7.8.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.7.8.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.9. United Arab Emirates
6.7.9.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.7.9.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.10. Others
6.7.10.1. Market Assessment and Forecast, By Product, 2017-2023($Million)
6.7.10.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
7. Company Profiles
7.1. Grifols
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Strategic Developments
7.1.4. Plasma Protein Therapeutics Sales, Revenue and Market Share
7.2. Chengdu Institute of Biological Products
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Strategic Developments
7.2.4. Plasma Protein Therapeutics Sales, Revenue and Market Share
7.3. Baxter International
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Strategic Developments
7.3.4. Plasma Protein Therapeutics Sales, Revenue and Market Share
7.4. Octapharma
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Strategic Developments
7.4.4. Plasma Protein Therapeutics Sales, Revenue and Market Share
7.5. China Biologic Products
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Strategic Developments
7.5.4. Plasma Protein Therapeutics Sales, Revenue and Market Share
7.6. Shire
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.6.4. Plasma Protein Therapeutics Sales, Revenue and Market Share
7.7. Biotest
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Strategic Developments
7.7.4. Plasma Protein Therapeutics Sales, Revenue and Market Share
7.8. CSL Behring
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Strategic Developments
7.8.4. Plasma Protein Therapeutics Sales, Revenue and Market Share
8. Global Plasma Protein Therapeutics Market Competition, by Manufacturer
8.1. Global Plasma Protein Therapeutics Sales and Market Share by Manufacturer (2017-2017)
8.2. Global Plasma Protein Therapeutics Revenue and Market Share by Manufacturer (2017-2017)
8.3. Top 5 Plasma Protein Therapeutics Manufacturer Market Share
8.4. Market Competition Trend
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Plasma Protein Therapeutics Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|